Clinical Trials Directory

Trials / Completed

CompletedNCT03046836

Oxytocin, Alcohol Craving, and Intimate Partner Aggression

Effects of Oxytocin on Alcohol Craving and Intimate Partner Aggression

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Alcohol use disorders (AUD) and intimate partner aggression (IPA) frequently co-occur. There are significant health and economic burdens associated with AUD and co-occurring IPA, and little empirical data to guide treatment efforts. The neuropeptide oxytocin may help mitigate both AUD and IPA. However, clinical data examining oxytocin's effects on human aggression is scant. The proposed study is designed to address these gaps in the literature by utilizing a human laboratory paradigm to test the effects of oxytocin on craving and aggression among couples with AUD and co-occurring IPA.

Conditions

Interventions

TypeNameDescription
DRUGOxytocin40 IU oxytocin nasal spray
DRUGPlaceboSaline

Timeline

Start date
2017-07-01
Primary completion
2021-04-11
Completion
2021-04-11
First posted
2017-02-08
Last updated
2022-05-09
Results posted
2022-05-09

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03046836. Inclusion in this directory is not an endorsement.

Oxytocin, Alcohol Craving, and Intimate Partner Aggression (NCT03046836) · Clinical Trials Directory